The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Mechanism of early radiographic response to imatinib in GIST.
J. Gao
No relevant relationships to disclose
J. C. McAuliffe
No relevant relationships to disclose
A. J. F. Lazar
Stock Ownership - Novartis (B)
Honoraria - Novartis
Research Funding - Novartis
W. Wang
No relevant relationships to disclose
H. Choi
No relevant relationships to disclose
K. Hunt
No relevant relationships to disclose
D. M. Araujo
No relevant relationships to disclose
R. E. Pollock
No relevant relationships to disclose
R. S. Benjamin
Consultant or Advisory Role - Novartis
Honoraria - Novartis
J. C. Trent
Research Funding - Novartis